Arcus Biosciences is an oncology-focused biopharmaceutical company leveraging its deep cross-disciplinary expertise to discover highly differentiated therapies and to develop a broad portfolio of novel combinations addressing significant unmet needs.

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

www.arcusbio.com →

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

News

After A 24% Drop, Is First Majestic Silver Nearing A Bottom?

Frontdoor Stock Pullback: A Buying Opportunity Or A Value Trap?

ICE Stock Trading at a Discount to Industry at 20.03X: Time to Hold?

GEHC & Springbok Collaborate on MRI Muscle Analysis for Sports

NDAQ Outperforms Industry, Trades at a Discount: How to Play the Stock

FDX Earnings Move a "Coin Flip:" Metrics & Options to Watch

SoundHound AI Sinks 6%: What NVIDIA's Voice AI Bet Says About the Broader Market

Iron Branch by Toll Brothers is Now Open in St. Augustine, Florida

Alibaba stock hands investors an AI business for free: find out more

It's Not Just Oil. The Iran War Sparked a Supply-Chain Mess That's Hitting Tech, Medicine, and More.

Procore Navigates CEO Transition And Challenged Construction Industry

BUI: Recent Correction Looks Like A Buying Opportunity

3 Surefire Stock Splits to Buy in 2026

Datadog Stock Surges 27% in a Year: Time to Hold or Book Profits?

Can Workday's AI Expansion Through Sana Boost Its Future Profits?

MPLX Boasts Resilient Pipeline Prospects, With Rich Distribution Growth

Tri-Continental Corporation Announcements Regarding 96th Annual Meeting of Stockholders

Columbia Seligman Premium Technology Growth Fund, Inc. Announcements Regarding 16th Annual Meeting of Stockholders

DELL's AI Server Momentum Surges: Can It Drive Long-Term Growth?

Here's Why Investors Should Give Freightcar America Stock a Miss Now

About